Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Artist Monica Magtoto, who was born and raised in San Francisco, described her utility box murals as love letters to the city. The one featured here is on the corner of Dolores and 15th Streets. Photo ...

The company's experimental once-daily version will become the first oral GLP-1 for chronic weight management, if approved. U.S.-listed shares of Novo added to session gains and were last up 5.72% at ...

Will “Thunderbolts” bring the box office thunder? Disney’s latest Marvel superhero adventure is targeting $70 million to $75 million in its opening weekend, providing another needed jolt to ...

Sunny Deol's 'Jaat,' released in 2025 after the success of 'Gadar 2,' is struggling at the box office. Despite a weekend surge, the film experienced a significant drop on its third Monday ...

After a poor opening to 2025, one may wonder why so many in the movie theater business repeated the mantra “Survive ’til ’25” if this was how a year without pandemic or strike-induced ...

Rybelsus (semaglutide) is a prescription drug that’s used to manage blood sugar levels in people with type 2 diabetes. This drug can interact with other medications, such as levothyroxine ...

Rybelsus (semaglutide) can cause side effects that range from mild to serious. More common side effects include constipation and diarrhea. If side effects from Rybelsus become difficult to ...

All products featured on GQ are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Let’s cut to it ...